SUMMARY Three pedigrees were identified in which mitral valve prolapse seemed to be inherited as a mendelian autosomal dominant trait. The segregation of the genes encoding the major fibrillar collagens present in valve tissue, collagens I and III, was analysed by use of restriction enzyme site variants as genetic markers. In one pedigree there was discordance between the segregation of the disease and markers for all three collagen genes. In another, there was discordance between the disease and markers for both collagen I loci. This is evidence against the disease being generally the result of mutations of the genes encoding the major fibrillar collagens.
Mitral valve prolapse is one ofthe commonest human cardiac abnormalities, with a prevalence of about 5%. However, it has also been recognised, through improvements in echocardiography, that there is considerable variation in mitral valve mobility in the healthy population. Nevertheless, mitral valve prolapse can be identified as a distinct entity by applying strict diagnostic criteria relating to the degree ofredundancy ofthe valve and the presence of mitral regurgitation. Most affected individuals are symptom free but a proportion suffer from atypical chest pain. Infective endocarditis, spontaneous cordal rupture, progressive mitral regurgitation, and sudden death are rare complications. The earliest histological change in mitral valve prolapse is disruption ofthe pars fibrosa with fragmentation ofcollagen bundles and an associated myxomatous degeneration. Subsequent changes include thickening of the endocardial surfaces and dilatation of the mitral annulus, both consequences of the stretching and elongation process initiated by the primary structural degeneration. The subject has been well reviewed. ' For the following reasons we set out to analyse the segregation of these three loci in pedigrees of dominantly inherited mitral valve prolapse. Firstly, if the primary defect in primary mitral valve prolapse is indeed a collagen defect then one possibility is that it is caused by a mutation in one of the structural genes. Mutations in these genes are known to cause some, but not all, of the inherited connective tissue disorders with which mitral valve prolapse can be associated. Secondly, although several other genes direct collagen synthesis, notably those encoding the eight enzymes that modify the protein after translation, the dominant inheritance of mitral valve prolapse suggests that the defect is likely to be in a structural protein Figure 1 shows the positions of the markers on the physical gene maps. Use of these three markers distinguished eight haplotypes at both COLlAl and COL1A2 with four possible combinations allowed at COL3A1. Table 2 shows the notations of markers at the three loci.
Where it was relevant to the analysis we confirmed paternity or maternity by means of the minisatellite probe 15. COL3A1-II.5 is homozygous for COL3A1 markers so the pedigree is not informative.
Individual I.1, who was not examined, was reported to have been turned down for army selection because ofa heart murmur. This raises the possibility that the gene for mitral valve prolapse is present in his sibs, one of whom is II.4, the father of the affected individuals in generation III. II.4 was thoroughly examined and no signs of mitral valve prolapse were seen by careful auscultation or echocardiography. Figure 2 shows the genotypes at the three loci and common disorder so that sibships may receive mitral valve prolapse genes from both parents. Second, the penetrance is incomplete. This makes analysis based on unaffected individuals more uncertain than in fully penetrant disorders because there is a high probability that they may have inherited the gene 
